Intra Cellular Therapies | Nettoeinkommen



Net Income Veränderung Datum
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
J&J USD 11B 7.57B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Prothena USD -57956000 1.04M 2024-12
RedHill Biopharma USD -1540000 0 2024-06
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
United Therapeutics USD 322.2M 20.9M 2025-03



Intra Cellular Therapies Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.